Germany
Japan
United Kingdom
China
Research Areas
View as table Download
Recombinant Anti-TNF alpha (Clone cA2 (Infliximab))
| Applications | ELISA, FC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-TNF alpha (Clone cA2 (Infliximab))
| Applications | ELISA, FC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-TNF alpha (Clone cA2 (Infliximab))
| Applications | ELISA, FC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
USD 420.00
4 Weeks
USD 420.00
4 Weeks
Active filters
Target Symbol
- TNF
Applications
- FC
Filter by
Category
Reactivities
Antibody Hosts
Clonalities
Conjugates
Modifications
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
Assay Types
Pathways
- Adipocytokine signaling pathway (8)
- Allograft rejection (8)
- Alzheimer's disease (8)
- Amyotrophic lateral sclerosis (ALS) (8)
- Apoptosis (8)
- Asthma (8)
- Cytokine-cytokine receptor interaction (8)
- Dilated cardiomyopathy (8)
- Fc epsilon RI signaling pathway (8)
- Graft-versus-host disease (8)
- Hematopoietic cell lineage (8)
- Hypertrophic cardiomyopathy (HCM) (8)
- MAPK signaling pathway (8)
- NOD-like receptor signaling pathway (8)
- Natural killer cell mediated cytotoxicity (8)
- RIG-I-like receptor signaling pathway (8)
- Systemic lupus erythematosus (8)
- T cell receptor signaling pathway (8)
- TGF-beta signaling pathway (8)
- Toll-like receptor signaling pathway (8)
- Type I diabetes mellitus (8)
- Type II diabetes mellitus (8)